Receptor-independent spread of a highly neurotropic murine coronavirus JHMV strain from initially infected microglial cells in mixed neural cultures

Journal of Virology

Volumn 79, Issue 10, 2005, Pages 6102-6110

  Nakagaki, Keiko ^a   Nakagaki, Kazuhide ^b   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CELL RECEPTOR; LECTIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; MICROGLIA; MOUSE; MURINE HEPATITIS CORONAVIRUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; SYNCYTIUM; TARGET CELL; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; ASTROCYTES; COCULTURE TECHNIQUES; CORONAVIRUS INFECTIONS; HEPATITIS ANTIBODIES; MICE; MICROGLIA; MURINE HEPATITIS VIRUS; MUTATION; NEURONS; OLIGODENDROGLIA; RECEPTORS, VIRUS; VIRULENCE; VIRUS REPLICATION;

CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 18144377732     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.10.6102-6110.2005     Document Type: Article

References (39)

1. Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarstrom, K. V. Holmes, A. Karlsson, M. Kuroki, S. H. Lin, L. Lucka, S. M. Najjar, M. Neumaier, B. Obrink, J. E. Shively, K. M. Skubitz, C. P. Stanners, P. Thomas, J. A. Thompson, M. Virji, S. von Kleist, C. Wagener, S. Watt, and W. Zimmermann, 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252:243-249.
2. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss, 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
3. Dveksler, G. S., C. W. Dieffenbach, C. B. Cardellichio, K. McCuaig, M. N. Pensiero, G. S. Jiang, N. Beauchemin, and K. V. Holmes, 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus A59. J. Virol. 67:1-8.
4. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G. S. Jiang, K. V. Holmes, and C. W. Dieffenbach, 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
5. Dveksler, G. S., M. N. Pensiero, C. W. Dieffenbach, C. B. Cardellichio, A. A. Basile, P. E. Elia, and K. V. Holmes, 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA 90:1716-1720.
6. Gallagher, T. M., and M. J. Buchmeier, 2001. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279:371-374.
7. Gallagher, T. M., M. J. Buchmeier, and S. Perlman, 1992. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology 191:517-522.
8. Godfraind, C., N. Havaux, K. V. Holmes, and J.-P. Coutelier, 1997. Role of virus receptor-bearing endothelial cells of the blood-brain barrier in preventing the spread of mouse hepatitis virus-A59 into the central nervous system. J. Neurovirol. 3:428-434.
9. Godfraind, C., S. G. Langreth, C. B. Cardellichio, R. Knobler, J. P. Coutelier, M. Dubois Dalcq, and K. V. Holmes, 1995. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab. Investig. 73:615-627.
10. Hirayama, M., D. H. Silberberg, R. P. Lisak, and D. Pleasure, 1983. Long-term culture of oligodendrocytes isolated from rat corps callosum by percoll density gradient. Lysis by polyclonal antigalactocerebroside serum. J. Neuropathol. Exp. Neurol. 42:16-28.
11. Kubo, H., S. Takase-Yoden, and F. Taguchi, 1993. Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variant. J. Gen. Virol. 74:1421-1425.
12. Kubo, H., Y. K. Yamada, and F. Taguchi, 1994. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:5403-5410.
13. Lai, M. M. C., and D. Cavanagh, 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
14. Lavi, E., A. Suzumura, M. Hirayama, M. K. Highkin, D. M. Dambach, D. H. Silberberg, and S. R. Weiss, 1987. Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb. Pathog. 3:79-86.
15. Matsuyama, S., and F. Taguchi, 2002. Receptor-induced conformational changes of murine coronavirus spike protein. J. Virol. 76:11819-11826.
16. Matsuyama, S., R. Watanabe, and F. Taguchi, 2001. Neurovirulence in mice of soluble receptor-resistant (srr) mutants of mouse hepatitis virus: intensive apoptosis caused by less virulent srr mutant. Arch. Virol. 146:1643-1654.
17. Miura, H. S., K. Nakagaki, and F. Taguchi, 2004. N-terminal domain of murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein. J. Virol. 78:216-223.
18. Nash, T. C., and M. J. Buchmeier, 1996. Spike glycoprotein-mediated fusion in biliary glycoprotein-independent cell-associated spread of mouse hepatitis virus infection. Virology 223:68-78.
19. Ohtsuka, N., K. Tsuchiya, E. Honda, and F. Taguchi, 2001. A study on mouse hepatitis virus receptor genotype in the wild mouse. Adv. Exp. Med. Biol. 494:237-240.
20. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman, 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641-1647.
21. Perlman, S., and D. Ries, 1987. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathog. 3:309-314.
22. Ramarkrishna, C., C. C. Bergmann, K. V. Holmes, and S. Stohlman, 2004. Expression of the mouse hepatitis virus receptor by central nervous system microglia. J. Virol. 78:7828-7832.
23. Saeki, K., N. Ohtsuka, and F. Taguchi, 1997. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol. 71:9024-9031.
24. Sodroski, J. G, 1999. HIV-1 entry inhibitors in the side pocket. Cell 99:243-246.
25. Stohlman, S. A., C. C. Bergmann, R. C. van der Veen, and D. R. Hinton, 1995. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69:684-694.
26. Streit, W. J, 1990. An improved staining method for rat microglial cells using the lectin Griffonia simplicifonia (GSA I-B4). J. Histochem. Cytochem. 11:1683-1686.
27. Sturman, L. S., C. S. Ricard, and K. V. Holmes, 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
28. Sun, N., and S. Perlman, 1995. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69:633-641.
29. Suzuki, H., and F. Taguchi, 1996. Analysis of the receptor-binding site of murine coronavirus spike protein. J. Virol. 70:2632-2636.
30. Taguchi, F., and S. Matsuyama, 2002. Soluble receptor potentiates receptor-independent infection by murine coronavirus. J. Virol. 76:950-958.
31. Taguchi, F., S. Matsuyama, and K. Saeki, 1999. Difference in Bgp-independent fusion activity among mouse hepatitis viruses. Arch. Virol. 1444:2041-2049.
32. Taguchi, F., S. G. Siddell, H. Wege, and V. ter Meulen, 1985. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 54:429-435.
33. Taguchi, F., A. Yamada, and K. Fujiwara, 1980. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages. Infect. Immun. 29:42-49.
34. Tatsuo, H., N. Ono, K., Tanaka, and Y. Yanagi, 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897.
35. Watt, S. M., A. M. Teixeira, GQ Zhou, R. Doyonnas, Y. Zhang, F. Grunert, R. S. Blumberg, M. Kuroki, K. M. Skubitz, and P. A. Bates, 2001. Homophilic adhesion of human CEACAM1 inovlves N-terminal domain interactions: structural analysis of the binding site. Blood 98:1469-1479.
36. Williams, R. K., G. S. Jiang, and K. V. Holmes, 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
37. Williams, R. K., G. S. Jiang, S. W. Snyder, M. F. Frana, and K. V. Holmes, 1990. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV) A59 from mouse liver and identification of a non-functional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64:3817-3823.
38. Wu, C. H., C. Y. Wen, J. Y. Shieh, and E. A. Ling, 1992. A quantitative and morphometric study of the transformation of amoeboid microglia into ramified microglia in the developing corpus callosum in rats. J. Anat. 181:423-430.
39. Yokomori, K., and M. M. Lai, 1992. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J. Virol. 66:6931-6938.